FindTrial
Sign In

The clinical outcome of adding low-dose hCG in early-follicular phase in women with PCOS undergoing controlled ovarian stimulation using Utrogestan andHMG protocol: a prospective, randomized, controlled trial

The clinical outcome of adding low-dose hCG in early-follicular phase in women with PCOS undergoing controlled ovarian stimulation using Utrogestan andHMG protocol: a prospective, randomized, controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15007165
Enrollment
Unknown
Registered
2015-10-01
Start date
2015-10-02
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Group A:Utrogestan andHMG protocol without hCG
Group B:Adding hCG from early-follicular phase in Utrogestan andHMG protocol

Sponsors

Shanghai Ninth Peoples Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: infertility women, aged 20-40 yearsPCOS

Exclusion criteria

Exclusion criteria: clinically significant systemic disease such as renal failure, endometrosis grade 3 or higher, any contraindications to ovarian stimulation treatment anddocumented poor ovarian response.

Design outcomes

Primary

MeasureTime frame
large preovulatory follicles;—

Secondary

MeasureTime frame
the occurrence of severe OHSS;the number of oocytes retrieved;premature LH surge;the number of mature oocytes;the number of good-quality embryos;clinical pregnancy rate;implantation rate;live birth rate;—

Countries

CHINA

Contacts

Public ContactYonglun Fu

Shanghai Ninth Peoples Hospital

fuyonglunivf@163.com+86 13917547302

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026